Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

被引：0
|
作者：
Kawazoe, Mai [1 ]
Nishio, Junko [1 ,2 ]
Hirose, Wataru [3 ]
Furukawa, Karin [1 ]
Nanki, Toshihiro [1 ]
机构：
[1] Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, 6-11-1 Omori Nishi, Ota Ku, Tokyo 1438541, Japan
[2] Toho Univ, Sch Med, Dept Immunopathol & Immunoregulat, Tokyo, Japan
[3] Hirose Clin Rheumatol, Saitama, Japan
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 115卷
关键词：
VACCINATION; AUTOIMMUNE;
D O I：
10.1016/j.ejim.2023.06.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [21] SAFETY OF BIVALENT SARS-COV-2 VACCINES AS A SECOND BOOSTER DOSE IN ARTHRITIS PATIENTS ON IMMUNOSUPPRESSIVE THERAPIES
    Orbo, H.
    Jyssum, I.
    Tveter, A. T.
    Christensen, I. E.
    Sexton, J.
    Bjorlykke, K. H.
    Kro, G. B.
    Kvien, T. K.
    Munthe, L. A.
    Grodeland, G.
    Mjaaland, S.
    Vaage, J. T.
    Haavardsholm, E. A.
    Jorgensen, K. K.
    Provan, S. Aarrestad
    Syversen, S. W.
    Goll, G. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 532 - 532
  • [22] Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions
    Klingel, Hanna
    Kruettgen, Alexander
    Imoehl, Matthias
    Kleines, Michael
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2023, 12 (01) : 60 - 69
  • [23] Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review
    Dhanasekaran, Preeti
    Karasu, Biraveena Thirunavuc
    Mak, Anselm
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (12) : 2757 - 2794
  • [24] DELAYED SKIN REACTIONS AND MRNA VACCINES AGAINST SARS-COV-2: CORRESPONDENCE
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    EXCLI JOURNAL, 2022, 21 : 1285 - 1285
  • [25] Safety of Sars-cov-2 Mrna Vaccines in Solid Organ Transplant Recipients
    Ou, M.
    Boyarsky, B.
    Motter, J.
    Greenberg, R.
    Teles, A.
    Ruddy, J.
    Krach, M.
    Werbel, W.
    Avery, R.
    Massie, A.
    Segev, D.
    Garonzik-Wang, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 418 - 418
  • [26] Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients
    Hirama, Takashi
    Akiba, Miki
    Shundo, Yuki
    Watanabe, Tatsuaki
    Watanabe, Yui
    Oishi, Hisashi
    Niikawa, Hiromichi
    Okada, Yoshinori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (08) : 1153 - 1158
  • [27] Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
    Paal, Michael
    Arend, Florian M.
    Lau, Tobias
    Hasmann, Sandra
    Soreth-Rieke, Daniela
    Sorodoc-Otto, Johanna
    Beuthien, Wilke
    Krappe, Julia
    Toepfer, Marcell
    von Gersdorff, Gero
    Thaller, Norbert
    Rau, Simon
    Northoff, Bernd
    Teupser, Daniel
    Bruegel, Mathias
    Fischereder, Michael
    Schoenermarck, Ulf
    CLINICAL KIDNEY JOURNAL, 2021, 14 (10) : 2234 - 2238
  • [28] Maintaining Safety with SARS-CoV-2 Vaccines
    Rolla, Giovanni
    Brussino, Luisa
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10):
  • [29] Maintaining Safety with SARS-CoV-2 Vaccines
    Castells, Mariana C.
    Phillips, Elizabeth J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 643 - 649
  • [30] Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents
    Koichi Kamei
    Masao Ogura
    Mai Sato
    Kentaro Nishi
    Kensuke Shoji
    Takanori Funaki
    Chikara Ogimi
    Shuichi Ito
    Pediatric Nephrology, 2023, 38 : 1099 - 1106
12345